World Drug Sales January-october 1995

15 January 1996

Sales of pharmaceuticals through retail pharmacies in the world's top 10 markets increased 8% in the first 10 months of 1995, to reach a total of $114.33 billion, according to new data from IMS International. This compares to an increase of 5% in the same period of 1994, it notes.

The largest growth reported during the period was in the Spanish market, which advanced 11% to $3.93 billion, followed by the USA, up 10% to $44.68 billion. Retail turnover in japan was up 9% to $21.92 billion, while UK sales advanced 8% to $5.15 billion, reports IMS. Increases of 7% were reported for both Germany, which rose to $13.66 billion, and for Belgium, advancing to $1.62 billion, while business in France and the Netherlands was up 6%, to $12.34 billion and $1.62 billion respectively. Retail sales in Canada advanced 5% to $2.96 billion in the period, and Italy reported growth of 4%, to $6.30 billion.

Sales growth in North America (USA and Canada combined) was 10%, reaching $47.64 billion, and in the top seven European markets combined, the increase was 7%, at $44.74 billion.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight